$LBRX
LB Pharmaceuticals Inc Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$36.74
▲+0.14%+$0.050
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLB Pharmaceuticals Inc Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LBRX up today? It is at $36.74 (+0.14%), and our scanner flagged it 86 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LBRX spikes, and full due diligence on LBRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LBRX 86 times in the last 30 days. Create a free account to track $LBRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LBRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LBRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Vida Ventures Gp Iii, L.L.C. Beneficial Owner (10%) | Acquired (grant/award) | +549K 1.7% of company | n/a | 548K | n/a | Sep 12, 25 |
Vida Ventures Gp Iii, L.L.C. Beneficial Owner (10%) | Bought (open market) | +333K 1.0% of company | added 61% | 884K | $5.0M at $15.00 | Sep 12, 25 |
Pontifax Management 4 G.P. (2015) Ltd. Beneficial Owner (10%) | Acquired (grant/award) | +412K 1.3% of company | n/a | 412K | n/a | Sep 12, 25 |
Pontifax Management 4 G.P. (2015) Ltd. Beneficial Owner (10%) | Bought (open market) | +1.00M 3.1% of company | added 100% | 1.82M | $15.0M at $15.00 | Sep 12, 25 |
Nussbaum Ran Director | Acquired (grant/award) | +412K 1.3% of company | n/a | 412K | n/a | Sep 12, 25 |
Nussbaum Ran Director | Bought (open market) | +1.00M 3.1% of company | added 100% | 1.82M | $15.0M at $15.00 | Sep 12, 25 |
Deep Track Biotechnology Master Fund, Ltd. Beneficial Owner (10%) | Acquired (grant/award) | +686K 2.1% of company | n/a | 686K | n/a | Sep 12, 25 |
Deep Track Biotechnology Master Fund, Ltd. Beneficial Owner (10%) | Bought (open market) | +2.00M 6.2% of company | added 100% | 2.69M | $30.0M at $15.00 | Sep 12, 25 |
Deep Track Biotechnology Master Fund, Ltd. Beneficial Owner (10%) | Bought (open market) | +667K 2.1% of company | n/a | 667K | $10.0M at $15.00 | Sep 12, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LBRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LBRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LBRX last traded at $36.74, up 0.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
LB Pharmaceuticals Inc Common Stock (LBRX) is next expected to report earnings on Thursday, November 5, 2026, about 18 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LBRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LBRX 86 times in the last 30 days.
LBRX (LB Pharmaceuticals Inc Common Stock) trades on XNAS, with a market cap of about $1.19B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LBRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LBRX discussion
Sign in to ask a question or join the discussion.